跳至主要内容
临床试验/NCT03940573
NCT03940573Unknown不适用

A Registry to Further Develop the Understanding of the Real World Use of the Eclipse System for Fecal Incontinence in Women

Pelvalon, Inc.11 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2019年4月19日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
150
试验地点
11
主要终点
Fit Rate

研究概览

简要总结

A prospective, open label post-market registry to collect Patient Reported Outcomes and Fitting metrics (e.g. sizes used) in subjects using the Eclipse System in a commercial setting.

详细描述

Up to 150 subjects enrolled, in up to 25 sites. Population of all adult female patients with Fecal Incontinence (FI) who present at, or are identified at, participating sites are eligible. This includes patients who are newly prescribed Eclipse, and those already using Eclipse who return for an annual renewal visit during the enrollment period.

Includes fitting of the patient for the Eclipse System with collection of relevant health history data. Patients are provided a temporary device for a trial usage period. Multiple device sizes may be attempted to find the correct fit for the patient, at which point the patient is provided with the long term use Eclipse Insert and enters the treatment period.

During the fitting and treatment period, patient experience will be assessed by surveys, St. Mark's (Vaizey) scores, and the validated global PGI-I index (Patient Global Impression of Improvement). Surveys will be perform at the fitting follow up and at 12 months of device usage, and optionally at 3, 6, and 9 months of device usage.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Adult female
  • Diagnosis of Fecal Incontinence
  • Clinician recommendation of the Eclipse System
  • Subject provides informed consent and HIPAA authorization
  • No Exclusion Criteria.

排除标准

  • 未提供

研究组 & 干预措施

Treatment

Experimental

All patients fitted with the device.

干预措施: Eclipse Insert (Device)

结局指标

主要结局

Fit Rate

时间窗: Data collected at fitting visits (max 3 attempts), 5-7 weeks from initial screening

Proportion of patients successfully fit

Device Size Distribution

时间窗: Data collected at fitting visits (max 3 attempts), 5-7 weeks from initial screening

Size distribution of devices among successfully fit patients

St. Mark's Score (Vaizey)

时间窗: 12 months

Change from baseline in mean scores (scored 0-24 with 0 = total continence and 24 = total incontinence)

PGI-I Score

时间窗: 12 months

Patient global impression of improvement score (7 point scale comparing current condition to baseline, from 1 = very much better to 7 = very much worse)

次要结局

  • PGI-I Score(9 months)
  • St. Mark's Score (Vaizey)(9 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (11)

Loading locations...

相似试验